Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil. (2021)
Attributed to:
nCoV: Rapid Clinical Development of ChAdOx1 nCoV-19
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41467-021-25982-w
PubMed Identifier: 34615860
Publication URI: http://europepmc.org/abstract/MED/34615860
Type: Journal Article/Review
Volume: 12
Parent Publication: Nature communications
Issue: 1
ISSN: 2041-1723